rofecoxib has been researched along with Coronary Occlusion in 1 studies
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| László, SB | 1 |
| Lázár, B | 1 |
| Brenner, GB | 1 |
| Makkos, A | 1 |
| Balogh, M | 1 |
| Al-Khrasani, M | 1 |
| Hutka, B | 1 |
| Mohammadzadeh, A | 1 |
| Kemény, Á | 1 |
| László, T | 1 |
| Scheich, B | 1 |
| Szabados, T | 1 |
| Kenyeres, É | 1 |
| Giricz, Z | 1 |
| Bencsik, P | 1 |
| Varga, ZV | 1 |
| Novák, J | 1 |
| Helyes, Z | 1 |
| Ferdinandy, P | 1 |
| Gyires, K | 1 |
| Zádori, ZS | 1 |
1 other study available for rofecoxib and Coronary Occlusion
| Article | Year |
|---|---|
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats.
Topics: Animals; Biomarkers; Cardiotonic Agents; Coronary Occlusion; Coronary Vessels; Cyclooxygenase 2; Cyc | 2020 |